Minor adverse reactions such as UTIs and candidiasis may have been underreported as patients may present to health services such as primary care physicians or community pharmacies, which were not part of the network
However, I believe its more likely that shortages are the result of unanticipated demand by patients with obesity and/or diabetes who have only recently become aware of this revolutionary medication
Okay, it's not a massive crash if you take it at appropriate doses and it's right for you, but it can produce a crash and a lethargy and a kind of brain fog after the next day or so
For reference, semaglutide shows a 12.4% PCB-adj weight loss at 68wks and ~4% PCB-adj reduction at 12 wks
Signs you may need to increase dose: minimal improvement after 4 weeks of consistent use, rapid healing that could progress further, or previous positive response to higher doses of related peptides
Thats over 6% of the worlds population, and the number is rising across all age groups